<?xml version="1.0" encoding="UTF-8"?>
<p id="par0225">CoVs utilize specific host factors for virus entry and replication. Specific monoclonal or polyclonal antibodies, peptides or functional inhibitors can target the host receptor. For example, anti-DPP4 mAbs inhibit MERS-CoV cell entry 
 <italic>in vitro</italic>
 <xref rid="bib0735" ref-type="bibr">[147]</xref>. For the treatment of SARS-CoV, small-molecule entry inhibitors such as 
 <italic>N</italic>-(2-aminoethyl)-1-aziridineethanamine (93, NAAE) inhibit the catalytic activity of ACE2 and SARS-CoV S-mediated cell-cell fusion 
 <italic>in vitro</italic>
 <xref rid="bib0740" ref-type="bibr">[148]</xref>.
</p>
